Site‐Specific Quadruple‐Functionalised Antibodies
Toby Journeaux(AstraZeneca (United Kingdom)), Gonçalo J. L. Bernardes(University of Lisbon), Jason G. Kettle(AstraZeneca (United Kingdom)), Monika Papworth(Discovery Centre), Thomas V. Murray(British Heart Foundation), Aldrin V. Vasco(University of Cambridge), Matt Gothard(AstraZeneca (United Kingdom)), Michael B. Geeson(Memorial Sloan Kettering Cancer Center)
Cited by 10
Related Papers
Inverse electron demand Diels–Alder reactions in chemical biology
|Chemical Society Reviews|2017|1.1k
METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation
|Molecular Cell|2021|359
Sustainable Polysulfides for Oil Spill Remediation: Repurposing Industrial Waste for Environmental Benefit
|Advanced Sustainable Systems|2018|168
Chemical and Enzymatic Methods for Post-Translational Protein–Protein Conjugation
|Journal of the American Chemical Society|2022|77
Platform for Orthogonal <i>N</i>-Cysteine-Specific Protein Modification Enabled by Cyclopropenone Reagents
|Journal of the American Chemical Society|2022|69